VINSON VARUGHESE: Open Payments
NPI 1922383231 · PLAINFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 19 payments from 10 companies in 2025. Trend: 2023 $1,000 · 2024 $304 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Corium, LLC | 3 | $45 |
| Lilly USA, LLC | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Tris Pharma Inc | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Almatica Pharma LLC | 1 | $16 |
| ABBVIE INC. | 1 | $14 |
Products named: INGREZZA, REXULTI, Azstarys, ZEPBOUND, TRINTELLIX, Dyanavel XR, AUSTEDO XR, Jornay PM.
Industry payments across NJ — which companies pay providers there.
